Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis: Cell Reports Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Parkinson's disease specific Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non functional interactions Communications Biology